Search Results - Xinmin Yu

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Changing ALK-TKI mechanisms of resistance in re-biopsies of ALK-rearranged NSCLC: ALK mutations followed by SCLC-like histologic transformation: A case report by Qiong He, Xinmin Yu, Junrong Yan, Xun Shi, Hongming Pan

    Published in Heliyon (2024-06-01)
    Get full text
    Article


  2. 2

    Chloride Ion Penetration Resistance of Reactive Powder Concrete with Mineral Admixtures by Xinmin YU, Hongji ZHANG, Dehong WANG, Yanzhong JU, Mengxin KANG, Yidan MA

    Published in Medžiagotyra (2024-05-01)
    Get full text
    Article


  3. 3

    Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib by Ying Jin, Chen Lin, Xun Shi, Qiong He, Junrong Yan, Xinmin Yu, Ming Chen

    Published in BMC Cancer (2022-05-01)
    Get full text
    Article


  4. 4

    A Low-Hydroxyl Quartz Glass Prepared by Using a Plasma Heat Source as the Flame and High-Purity Quartz Sand as the Raw Material by Xinmin Yu, Xiurong Du, Xuefu Song, Yongchang Zhu, Xing Liu, Lisheng Zhou, Xueyi Zhu, Kai Qiu

    Published in Applied Sciences (2024-10-01)
    Get full text
    Article


  5. 5

    Efficacy of Icotinib for Advanced Non-small Cell Lung Cancer Patients with EGFR Status Identified by Yiping ZHANG, Beibei ZHANG, Chunxiao HE, Baochai LIN, Lan SHAO, Jufen CAI, Xinmin YU, Zhengbo SONG

    Published in Chinese Journal of Lung Cancer (2013-03-01)
    Get full text
    Article


  6. 6

    An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD‐(L)1 Inhibitor by Xun Shi, Chen Lin, Lishu Lou, Qiong He, Guangyuan Lou, Wei Hong, Lan Shao, Jun Zhao, Cuiping Gu, Xinmin Yu, Ying Jin

    Published in Cancer Medicine (2025-09-01)
    Get full text
    Article


  7. 7

    Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial by Tianqing Chu, Hua Zhong, Zhuang Yu, Jing Wang, Yanqiu Zhao, Xiaoqian Mu, Xinmin Yu, Xun Shi, Qingming Shi, Maojing Guan, Cuimin Ding, Nan Geng, Jialin Qian, Baohui Han

    Published in Cancer Communications (2025-04-01)
    Get full text
    Article


  8. 8

    Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy by Jing Wang, Jie Liu, Yan Zhang, Hua Zhong, Xinmin Yu, Lijuan Chen, Xueyan Zhang, Panwen Tian, Tianqing Chu, Qisen Guo, Zhuang Yu, Yalun Li, Yan Guan, Xun Shi, Yanqiu Zhao, Baohui Han

    Published in Journal for ImmunoTherapy of Cancer (2023-08-01)
    Get full text
    Article


  9. 9

    Tunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I study by Yuankai Shi, Xiaohong Han, Qian Zhao, YuLong Zheng, Jianhua Chen, Xinmin Yu, Jian Fang, Yutao Liu, Dingzhi Huang, Tianshu Liu, Hong Shen, Suxia Luo, Hongsheng Yu, Yu Cao, Xi Zhang, Pei Hu

    Published in Experimental Hematology & Oncology (2024-06-01)
    Get full text
    Article


  10. 10

    SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer by Hui Li, Mark Voskoboynik, Qing Zhou, Hongming Pan, Juan Zhang, Yi-Long Wu, Bo Gao, Jun Zhao, Yunpeng Liu, Qian Chu, Lifeng Wang, Jiuwei Cui, Daphne Day, Xinmin Yu, Dingzhi Huang, Zhiyong Ma, Meili Sun, Jingxun Wu, Zhehai Wang, Yanyan Peng

    Published in Journal for ImmunoTherapy of Cancer (2023-02-01)
    Get full text
    Article


  11. 11

    Microneedle Patch for In Situ Neutrophil Monitoring by Ziyi Lu, Ruisi Cai, Tianao Xie, Sheng Zhao, Sarun Juengpanich, Win Topatana, Shijie Li, Jiasheng Cao, Jiahao Hu, Tianen Chen, Jiachen Chen, Jicheng Yu, Tao Sheng, Wentao Zhang, Hao Wang, Jiahuan You, Yukai Shan, Yuchao Sun, Ruijing Shen, Zhengjie Zhao, Kangfan Ji, Ziqi Gao, Xinmin Yu, Xiujun Cai, Zhen Gu, Yuqi Zhang, Mingyu Chen

    Published in Advanced Science (2025-06-01)
    Get full text
    Article


  12. 12

    Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm p... by Dan-Yun Ruan, Wen-Wen Huang, Yongsheng Li, Yanqiu Zhao, Yehui Shi, Yuming Jia, Shundong Cang, Wei Zhang, Jianhua Shi, Jun Chen, Jie Lin, Yunpeng Liu, Jianming Xu, Weiwei Ouyang, Jian Fang, Wu Zhuang, Caigang Liu, Qing Bu, Manxiang Li, Xiangjiao Meng, Meili Sun, Nong Yang, Xiaorong Dong, Yueyin Pan, Xingya Li, Xiujuan Qu, Tongmei Zhang, Xianglin Yuan, Sheng Hu, Wei Guo, Yalun Li, Shengqing Li, Dongying Liu, Feixue Song, Liping Tan, Yan Yu, Xinmin Yu, Aimin Zang, Chang Sun, Qian Zhang, Kai Zou, Mo Dan, Rui-Hua Xu, Hongyun Zhao

    Published in Signal Transduction and Targeted Therapy (2025-02-01)
    Get full text
    Article


  13. 13

    Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III tri... by Shun Lu, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhi Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lu, Yanping Hu, Liyan Jiang, Qiming wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wancheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Jie Weng, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Hongying Wei, Jiawei Wei, Zheyu Zhang, Qiong Wu

    Published in Cancer Communications (2024-09-01)
    Get full text
    Article


Search Tools: